FARSB and hepatocellular carcinoma: Similar with the results above, the survival curves and ROC curves drawn by R software proved that the high-expressed FARSB was strongly linked with the low overall survival rate, and AUC of the prognosis model at 1, 3 and 5 years was 0.687, 0.670, and, 0.618, respectively, inferring that overexpression of FARSB led to poor prognosis of HCC patients is accurate (Figure 4A, 4B).